iShares Select U.S. REIT ETF (ICF)
Live price chart, market sentiment, and community perspectives for iShares Select U.S. REIT ETF (CBOE: ICF).
Live price chart, market sentiment, and community perspectives for iShares Select U.S. REIT ETF (CBOE: ICF).
Valuation on iShares Select U.S. REIT ETF (ICF) (ICF) is stretched relative to sovereign debt yields, but short interest is too crowded to bet on immediate downside.
On our macro desk, we are viewing ICF's valuation through the lens of its P/CF ratio of roughly 16.1x against a category average of 13.9x. The concentration is undeniable: the top 10 holdings swallow up 59% of the fund's assets, steered heavily by Welltower, Prologis, and Equinix. Market sentiment is delicately balanced on CME FedWatch rate-cut probabilities for late 2026. If the 10-year Treasury breaks cleanly past 4.75%, the tight yield spread argument falls apart quickly. For now, the fund sits comfortably in an early-to-mid recovery phase with a monthly RSI of 54.2.
In our clinic meetings examining capital allocation, we note that approximately a third of ICF's portfolio is tied to demographic and technological structural shifts—specifically aging-population healthcare housing via Welltower and Ventas, alongside AI-driven data demand via Equinix and Digital Realty. Technical metrics show the fund trading roughly 3.2% above its 200-day moving average of $61.50 at $63.50. When allocating, analysts must respect that this is a non-diversified vehicle holding strictly 34 names, eliminating mortgage REIT and bond dilution entirely.
Watching the 50-day moving average and broader inflation prints, our risk management group flags the modest 2.44% SEC yield relative to prevailing risk-free rates. While trailing returns show a 1-year total return of 13.56% and a Morningstar 3-star rating against 198 peers, the structural risk lies in its sensitivity to macro catalysts like upcoming CPI releases and FOMC decisions. Investors treating this as a simple income proxy might be disappointed by the low dividend yield; the thesis here fundamentally relies on structural cash-flow growth from industrial logistics and data infrastructure assets.
Explore plasma cleansing, somatic organ swaps, and BCI.